O. Schnider

652 total citations
26 papers, 292 citations indexed

About

O. Schnider is a scholar working on Organic Chemistry, Oncology and Pharmacology. According to data from OpenAlex, O. Schnider has authored 26 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 9 papers in Oncology and 9 papers in Pharmacology. Recurrent topics in O. Schnider's work include Cancer Treatment and Pharmacology (9 papers), Plant-based Medicinal Research (9 papers) and Chemical synthesis and alkaloids (7 papers). O. Schnider is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Plant-based Medicinal Research (9 papers) and Chemical synthesis and alkaloids (7 papers). O. Schnider collaborates with scholars based in Switzerland and United States. O. Schnider's co-authors include A. BROSSI, A. Grüssner, Michael G. Walter, L. H. Chopard‐dit‐Jean, H. Lindlar, J. Würsch, F Schneider, O. Häfliger, K. Vogler and E. Hardegger and has published in prestigious journals such as Cellular and Molecular Life Sciences, Helvetica Chimica Acta and Monatshefte für Chemie - Chemical Monthly.

In The Last Decade

O. Schnider

26 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Schnider Switzerland 11 179 77 42 29 26 26 292
Hiroshi Kugita United States 10 253 1.4× 125 1.6× 44 1.0× 13 0.4× 32 1.2× 51 366
K. ISHIZUMI Japan 8 184 1.0× 116 1.5× 23 0.5× 52 1.8× 24 0.9× 23 294
Yvon G. Perron United Kingdom 12 201 1.1× 151 2.0× 22 0.5× 21 0.7× 47 1.8× 23 376
Glenn E. Ullyot United Kingdom 9 112 0.6× 75 1.0× 13 0.3× 21 0.7× 11 0.4× 24 203
Lars‐Inge Olsson Sweden 15 312 1.7× 81 1.1× 36 0.9× 21 0.7× 24 0.9× 27 513
John H. Dygos United States 9 149 0.8× 138 1.8× 17 0.4× 11 0.4× 35 1.3× 16 299
Richard N. Booher United States 8 97 0.5× 148 1.9× 33 0.8× 39 1.3× 50 1.9× 11 329
Kimio Takahashi Japan 10 288 1.6× 74 1.0× 38 0.9× 8 0.3× 10 0.4× 46 361
O Stephenson United Kingdom 13 274 1.5× 166 2.2× 16 0.4× 15 0.5× 8 0.3× 44 416
Gerald F. Holland United States 11 178 1.0× 164 2.1× 10 0.2× 14 0.5× 23 0.9× 20 380

Countries citing papers authored by O. Schnider

Since Specialization
Citations

This map shows the geographic impact of O. Schnider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Schnider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Schnider more than expected).

Fields of papers citing papers by O. Schnider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Schnider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Schnider. The network helps show where O. Schnider may publish in the future.

Co-authorship network of co-authors of O. Schnider

This figure shows the co-authorship network connecting the top 25 collaborators of O. Schnider. A scholar is included among the top collaborators of O. Schnider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Schnider. O. Schnider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grüssner, A., M. Montavon, & O. Schnider. (1965). Disubstituierte 4-Sulfanilamido-pyrimidine. Monatshefte für Chemie - Chemical Monthly. 96(6). 1677–1689. 2 indexed citations
2.
Schnider, O., et al.. (1965). Hydrierte Derivate von Benz[f]- und Benz[g]isochinolinen. Monatshefte für Chemie - Chemical Monthly. 96(1). 9–24. 2 indexed citations
3.
Schnider, O., et al.. (1964). Aminométhoxypyridines er sulfanilanides correspondants. Helvetica Chimica Acta. 47(2). 363–379. 13 indexed citations
4.
Walter, Michael G., et al.. (1963). Synthesen in der Isochinolinreihe Substituierte 1‐[ω‐(Nitrophenyl)alkyl]‐1,2,3,4‐tetrahydro‐isochinoline. Helvetica Chimica Acta. 46(4). 1127–1132. 4 indexed citations
5.
Walter, Michael G., et al.. (1961). Synthesen in der Isochinolinreihe 1,2‐substituierte Octahydroisochinoline. Helvetica Chimica Acta. 44(6). 1546–1554. 19 indexed citations
6.
BROSSI, A., L. H. Chopard‐dit‐Jean, J. Würsch, & O. Schnider. (1960). Syntheseversuche in der Emetin‐Reihe. 7. Mitteilung. Abbau und Synthese substituierter 2‐Oxo‐hydrobenzo[a]chinolizine. Helvetica Chimica Acta. 43(2). 583–593. 11 indexed citations
7.
Corrodi, H., et al.. (1959). Hydroxy‐morphinane. 12. Mitteilung. Die Konfiguration der Morphinane. Helvetica Chimica Acta. 42(1). 212–217. 3 indexed citations
8.
BROSSI, A., et al.. (1959). 727. Chemical constitution and amœbicidal action. Part V. Stereochemistry of emetine. Journal of the Chemical Society (Resumed). 0(0). 3630–3632. 4 indexed citations
9.
BROSSI, A., J. Würsch, & O. Schnider. (1958). Syntheseversuche in der Emetin-Reihe. CHIMIA International Journal for Chemistry. 12(4). 114–114. 3 indexed citations
10.
BROSSI, A., H. Lindlar, Michael G. Walter, & O. Schnider. (1958). Syntheseversuche in der Emetin‐Reihe. 1. Mitteilung. 2‐Oxo‐hydrobenzo[a]chinolizine. Helvetica Chimica Acta. 41(1). 119–139. 48 indexed citations
11.
BROSSI, A., L. H. Chopard‐dit‐Jean, & O. Schnider. (1958). Syntheseversuche in der Emetin‐Reihe. 3. Mitteilung. 2‐Hydroxy‐hydrobenzo[a]chinolizine. Helvetica Chimica Acta. 41(6). 1793–1806. 18 indexed citations
12.
Schnider, O., et al.. (1958). Synthèse d'amino‐5‐pyrimidines et des sulfanilamids correspondants. Helvetica Chimica Acta. 41(6). 1806–1816. 11 indexed citations
13.
Grüssner, A., et al.. (1957). Hydroxy‐morphinane. 11. Mitteilung. N‐Arylalkyl‐morphiane. Helvetica Chimica Acta. 40(5). 1232–1241. 3 indexed citations
14.
Häfliger, O., A. BROSSI, L. H. Chopard‐dit‐Jean, Michael G. Walter, & O. Schnider. (1956). Hydroxy‐Morphinane. Mitteilung. Über ein Photooxydationsprodukt von (+)‐3‐Methoxy‐N‐methyl‐morphinan. Helvetica Chimica Acta. 39(7). 2053–2062. 11 indexed citations
15.
BROSSI, A. & O. Schnider. (1956). Hydroxy‐Morphinane. 9. Mitteilung. Versuche zur Racemisierung optisch aktiver 1‐(p‐Hydroxybenzyl)‐1,2,3,4,5,6,7,8‐octahydro‐isochinoline. Helvetica Chimica Acta. 39(5). 1376–1386. 10 indexed citations
16.
Grüssner, A., et al.. (1956). Hydroxy‐morphinane. 7. Mitteilung. (−)‐3‐Hydroxy‐N‐allyl‐morphinan und verwandte Verbindungen. Helvetica Chimica Acta. 39(2). 429–440. 7 indexed citations
17.
Grüssner, A., et al.. (1956). Hydroxy‐morphinane. Mitteilung. Über die Konstitution der Nebenprodukte bei Morphinanringschlüssen. Helvetica Chimica Acta. 39(5). 1371–1376. 4 indexed citations
18.
Schnider, O., A. BROSSI, & K. Vogler. (1954). Oxy‐morphinane. 5. Mitteilung. Optisch aktive Benzyl‐octahydro‐isochinoline. Helvetica Chimica Acta. 37(3). 710–720. 5 indexed citations
19.
Schnider, O., et al.. (1954). Synthese neuer Schlafmittel der Pyridin- und Piperidinreihe. Cellular and Molecular Life Sciences. 10(3). 135–137. 9 indexed citations
20.
Schnider, O. & A. Grüssner. (1951). Oxy‐morphinane. (3. Mitteilung). Optisch aktive 3‐Oxy‐morphinane. Helvetica Chimica Acta. 34(7). 2211–2217. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026